Opko Health, Inc. (OPK) Financial Statements (2023 and Earlier)

Company Profile

Business Address 4400 BISCAYNE BLVD.
MIAMI, FL 33137
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments139861049691169194
Cash and cash equivalents13572859691169194
Short-term investments41419    
Receivables260286135144166220194
Inventory, net of allowances, customer advances and progress billings871325342494740
Inventory871325342494740
Prepaid expense15111213121111
Assets held-for-sale, not part of disposal group315      
Other current assets65164481
Other undisclosed current assets22418222915
Total current assets:823523324318343484454
Noncurrent Assets
Operating lease, right-of-use asset443839
Property, plant and equipment   145147123132
Long-term investments and receivables11162131414135
Long-term investments11162131414135
Intangible assets, net (including goodwill)8421,1561,2011,9502,0482,1132,174
Goodwill521681672700717705743
Intangible assets, net (excluding goodwill)3224755291,2501,3311,4091,430
Other noncurrent assets101077665
Other undisclosed noncurrent assets670731717    
Total noncurrent assets:1,5771,9501,9852,1332,2412,2832,346
TOTAL ASSETS:2,4002,4732,3092,4512,5852,7672,800
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities276342227251289251240
Accounts payable821016347745373
Accrued liabilities193241165204215198168
Debt  126121211
Disposal group, including discontinued operation28      
Other undisclosed current liabilities26341032   
Total current liabilities:330375249288301263252
Noncurrent Liabilities
Long-term debt and lease obligation22125228    
Long-term debt, excluding current maturities188222     
Operating lease, liability333028
Liabilities, other than long-term debt164174207199220202519
Deferred tax liabilities, net   226
Deferred income tax liabilities148137119
Other liabilities153788199220202292
Other undisclosed noncurrent liabilities  21117217820949
Total noncurrent liabilities:385426445371398412568
Total liabilities:715802695660699675820
Stockholders' equity
Stockholders' equity attributable to parent1,6851,6721,6151,7911,8852,0921,980
Common stock7776665
Treasury stock, value(2)(2)(2)(2)(2)(2)(4)
Additional paid in capital3,2223,1533,1433,0042,8892,8452,705
Accumulated other comprehensive loss(30)(4)(22)(20)(1)(27)(23)
Accumulated deficit(1,512)(1,482)(1,511)(1,197)(1,007)(730)(705)
Total stockholders' equity:1,6851,6721,6151,7911,8852,0921,980
TOTAL LIABILITIES AND EQUITY:2,4002,4732,3092,4512,5852,7672,800

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,7751,4359029901,0681,222492
Revenue, net1,0681,222492
Cost of revenue
(Cost of Goods and Services Sold)
(7)(4)(2)(2)(5)(564)(193)
Gross profit:1,7681,4319009881,062658298
Operating expenses(1,756)(1,378)(1,176)(1,161)(1,348)(1,295)(590)
Other undisclosed operating income74225564193
Operating income (loss):1958(274)(171)(280)(73)(98)
Nonoperating income (expense)(33)(9)(31)(6)5(0)(40)
Investment income, nonoperating100303(39)
Other nonoperating income (expense)(15)13(11)21048
Interest and debt expense(2)(1)(1)(0)(0)(0)1
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes211000(1)
Income (loss) from continuing operations before equity method investments, income taxes:(14)49(305)(177)(276)(74)(138)
Loss from equity method investments(1)  (14)(14)(8)(7)
Income (loss) from continuing operations before income taxes:(15)49(305)(192)(290)(81)(145)
Income tax expense (benefit)(15)(18)(7)39(19)56114
Net income (loss):(30)31(312)(153)(309)(25)(31)
Net income attributable to noncontrolling interest      1
Other undisclosed net income (loss) attributable to parent0(0)(3)    
Net income (loss) available to common stockholders, diluted:(30)31(315)(153)(309)(25)(30)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(30)31(312)(153)(309)(25)(31)
Other comprehensive loss      (10)
Other undisclosed comprehensive income (loss)   (20)26(4) 
Comprehensive income (loss):(30)31(312)(173)(282)(30)(42)
Comprehensive income, net of tax, attributable to noncontrolling interest      1
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(26)17(5)    
Comprehensive income (loss), net of tax, attributable to parent:(56)48(317)(173)(282)(30)(40)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: